StageZero Life Sciences Management
Management criteria checks 2/4
We currently do not have sufficient information about the CEO.
Key information
James Howard-Tripp
Chief executive officer
US$270.0k
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 7.7yrs |
| CEO ownership | 0.2% |
| Management average tenure | no data |
| Board average tenure | 15.9yrs |
Recent management updates
CEO
James Howard-Tripp
7.7yrs
Tenure
US$270,000
Compensation
Mr. James R. Howard-Tripp has been the Executive Chairman of StageZero Life Sciences Ltd. (formerly known as GeneNews Limited) (also known as ChondroGene Ltd.) since July 12, 2013 and has been its Chief Ex...
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Executive Chairman & CEO | 22.3yrs | US$270.00k | 0.19% $ 9.3k | |
| Independent Director | 24.3yrs | US$40.00k | 10.15% $ 501.7k | |
| Independent Director | 23.9yrs | US$40.00k | 0.12% $ 5.9k | |
| Member of Colorectal Cancer Clinical Advisory Board | 15.4yrs | no data | no data | |
| Member of Colorectal Cancer Clinical Advisory Board | no data | no data | no data | |
| Member of Colorectal Cancer Clinical Advisory Board | 15.4yrs | no data | no data | |
| Independent Director | 15.9yrs | US$40.00k | 0.087% $ 4.3k | |
| Member of Colorectal Cancer Clinical Advisory Board | no data | no data | no data | |
| Chairman of Colorectal Cancer Clinical Advisory Board | 16.8yrs | no data | no data | |
| Member of Colorectal Cancer Clinical Advisory Board | no data | no data | no data | |
| Member of Colorectal Cancer Clinical Advisory Board | 15.4yrs | no data | no data | |
| Member of Colorectal Cancer Clinical Advisory Board | 15.4yrs | no data | no data |
15.9yrs
Average Tenure
70yo
Average Age
Experienced Board: SZLS's board of directors are seasoned and experienced ( 15.9 years average tenure).